Credit Suisse Ag Bio Rad Laboratories, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 25,397 shares of BIO stock, worth $8.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,397

Previous 32,067 20.8%

Holding current value

$8.4 Million

Previous $10.4 Million 15.16%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$304.11 - $351.99 $2.03 Million - $2.35 Million	-6,670 Reduced 20.8%	25,397 $8.78 Million
Q4 2023 Feb 08, 2024	BUY	$269.37 - $365.04 $758,007 - $1.03 Million	2,814 Added 9.62%	32,067 $10.4 Million
Q3 2023 Nov 13, 2023	SELL	$350.25 - $422.63 $2.18 Million - $2.63 Million	-6,229 Reduced 17.56%	29,253 $10.5 Million
Q2 2023 Aug 11, 2023	SELL	$359.49 - $486.4 $2.87 Million - $3.89 Million	-7,993 Reduced 18.39%	35,482 $13.5 Million
Q1 2023 May 10, 2023	BUY	$418.69 - $503.0 $4.15 Million - $4.99 Million	9,914 Added 29.54%	43,475 $20.8 Million
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $779,741 - $1.01 Million	-2,217 Reduced 6.2%	33,561 $14.1 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $425,380 - $580,721	1,031 Added 2.97%	35,778 $14.9 Million
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $2.04 Million - $2.63 Million	-4,407 Reduced 11.26%	34,747 $17.2 Million
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $83,406 - $116,931	-159 Reduced 0.4%	39,154 $22.1 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $52.2 Million - $58.5 Million	-73,621 Reduced 65.19%	39,313 $29.7 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $16.1 Million - $20.3 Million	-24,554 Reduced 17.86%	112,934 $84.2 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $32.9 Million - $37 Million	56,990 Added 70.8%	137,488 $88.8 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $13.7 Million - $16.6 Million	25,031 Added 45.13%	80,498 $46 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $4.4 Million - $5.54 Million	8,610 Added 18.38%	55,467 $32.3 Million
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $705,275 - $831,251	1,552 Added 3.43%	46,857 $24.2 Million
Q2 2020 Aug 12, 2020	BUY	$334.87 - $493.06 $2.98 Million - $4.39 Million	8,900 Added 24.45%	45,305 $20.5 Million
Q1 2020 May 13, 2020	BUY	$320.01 - $409.07 $2.12 Million - $2.71 Million	6,616 Added 22.21%	36,405 $12.8 Million
Q4 2019 Feb 12, 2020	SELL	$319.73 - $374.2 $88,245 - $103,279	-276 Reduced 0.92%	29,789 $11 Million
Q3 2019 Nov 12, 2019	BUY	$304.55 - $345.24 $2.73 Million - $3.1 Million	8,965 Added 42.49%	30,065 $10 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $375,591 - $409,180	1,309 Added 6.61%	21,100 $6.6 Million
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $184,150 - $260,593	-821 Reduced 3.98%	19,791 $6.05 Million
Q4 2018 Feb 13, 2019	SELL	$220.1 - $309.0 $870,495 - $1.22 Million	-3,955 Reduced 16.1%	20,612 $4.79 Million
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $270,187 - $304,624	934 Added 3.95%	24,567 $7.69 Million
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $572,658 - $712,902	-2,346 Reduced 9.03%	23,633 $6.82 Million
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $225,547 - $264,242	964 Added 3.85%	25,979 $6.5 Million
Q4 2017 Feb 14, 2018	SELL	$216.94 - $271.3 $5.36 Million - $6.71 Million	-24,720 Reduced 49.7%	25,015 $5.97 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $3.14 Million - $3.58 Million	14,796 Added 42.35%	49,735 $11.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,939	34,939 $7.91 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account